Cencora to Acquire EyeSouth Partners' Retina Business for $1.1 Billion, Expanding RCA
COR sits 24% above its 52-week low of $264.33 on elevated volume (2.4× avg).
Summary
Cencora is acquiring EyeSouth Partners' retina business for $1.1 billion to expand its Retina Consultants of America, a move expected to be accretive to EPS.
Key Events · M&A and Partnerships · COR
-
Strategic Acquisition Announced
Cencora entered a definitive agreement on March 21, 2026, to acquire EyeSouth Partners' retina business for $1.1 billion.
-
Expansion of Retina Consultants of America
The acquisition will integrate EyeSouth Partners' retina physicians into Cencora's Retina Consultants of America (RCA), strengthening its management services organization network.
-
Expected Financial Impact
The transaction is anticipated to be slightly accretive to Cencora's adjusted diluted EPS within the first twelve months post-closing, net of financing costs.
-
Fiscal 2026 Guidance Reaffirmed
Cencora reaffirmed its fiscal 2026 financial guidance, noting that the acquisition is not yet factored into the current outlook.
Analysis · COR · Trade & Services
This 8-K announces Cencora's definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion, a strategic move to expand its Retina Consultants of America (RCA) management services organization. The acquisition is expected to be slightly accretive to adjusted diluted EPS within the first year post-closing, reinforcing Cencora's commitment to community physicians and advancing sight-saving treatments. The company's reaffirmation of fiscal 2026 guidance suggests confidence in its overall financial outlook despite this significant transaction.
At the time of this filing, COR was trading at $326.76 on NYSE in the Trade & Services sector, with a market capitalization of approximately $63.6B. The 52-week trading range was $264.33 to $377.54. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.